Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 4:15 pm Sale |
2024-12-31 | 13G | GitLab Inc. GTLB |
GV 2017, L.P. | 6,091,238 4.300% |
-3,667,095 (-37.58%) |
Filing History |
| 2024-11-08 4:20 pm Purchase |
2024-09-30 | 13G | Benson Hill, Inc. BHIL |
GV 2017, L.P. | 444,349 7.300% |
444,349 (New Position) |
Filing History |
| 2024-11-08 4:15 pm Sale |
2024-09-30 | 13G | GitLab Inc. GTLB |
GV 2017, L.P. | 9,758,333 7.100% |
-1,777,755 (-15.41%) |
Filing History |
| 2024-02-09 4:08 pm Unchanged |
2023-12-31 | 13G | TScan Therapeutics, Inc. TCRX |
GV 2017, L.P. | 1,077,080 2.500% |
0 (Unchanged) |
Filing History |
| 2024-02-09 4:06 pm Purchase |
2023-12-31 | 13G | GitLab Inc. GTLB |
GV 2017, L.P. | 11,536,088 9.900% |
713,578 (+6.59%) |
Filing History |
| 2023-12-11 4:16 pm Purchase |
2023-12-01 | 13G | Verve Therapeutics, Inc. VERV |
GV 2017, L.P. | 12,349,086 15.400% |
1,800,000 (+17.06%) |
Filing History |
| 2023-03-24 4:15 pm Purchase |
2023-03-14 | 13G | GitLab Inc. GTLB |
GV 2017, L.P. | 10,822,510 10.800% |
639,207 (+6.28%) |
Filing History |
| 2023-02-10 4:05 pm Purchase |
2022-12-31 | 13G | Benson Hill, Inc. BHIL |
GV 2017, L.P. | 509,985 8.700% |
88,491 (+20.99%) |
Filing History |
| 2023-02-10 4:05 pm Purchase |
2022-12-31 | 13G | GitLab Inc. GTLB |
GV 2017, L.P. | 10,183,303 10.200% |
1,294,527 (+14.56%) |
Filing History |
| 2023-02-10 4:05 pm Sale |
2022-12-31 | 13G | Verve Therapeutics, Inc. VERV |
GV 2017, L.P. | 10,549,086 17.100% |
-424,925 (-3.87%) |
Filing History |
| 2022-02-14 5:15 pm Purchase |
2021-12-31 | 13G | Verve Therapeutics, Inc. VERV |
GV 2017, L.P. | 10,974,011 22.780% |
10,974,011 (New Position) |
Filing History |
| 2022-02-14 4:14 pm Purchase |
2021-12-31 | 13G | GitLab Inc. GTLB |
GV 2017, L.P. | 8,888,776 41.360% |
8,888,776 (New Position) |
Filing History |
| 2022-02-14 1:07 pm Purchase |
2021-12-31 | 13G | Benson Hill, Inc. BHIL |
GV 2017, L.P. | 421,493 8.290% |
421,493 (New Position) |
Filing History |
| 2022-02-14 11:39 am Purchase |
2021-12-31 | 13G | TScan Therapeutics, Inc. TCRX |
GV 2017, L.P. | 1,077,080 5.780% |
1,077,080 (New Position) |
Filing History |